From an article in Molecular Medicine by Andreas A Argyriou
(Mol Med. 2009 Jul–Aug; 15(7-8): 283–287. Published online 2009 May 5. doi: 10.2119/molmed.2009.00041.)
“Conventional treatment options, including corticosteroids, intravenous immunoglobulin, or plasma exchange,
[B][COLOR=”Red”]often fail to treat[/COLOR][/B] (Color and Italics are mine)
dysimmune neuropathies, such as
chronic inflammatory demyelinating polyneuropathy,
multifocal motor neuropathy, and
monoclonal gammopathy with its subtypes.
…the need for the development of safe and effective new treatment options is rising. Currently, …”
Wanna know more? To navigate to the link, highlight the green text, copy (ctrl + C) the green link and paste (Crtl + V) it into your browser’s address bar.
[COLOR=”SeaGreen”]http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707512/[/COLOR]
Thanks to ms. judy for her question!
You must be logged in to reply to this topic.
© Copyright GBS|CIDP Foundation International Forums.
Use of this Web site constitutes acceptance of our Terms of Use and Privacy Policy.
GBS|CIDP Foundation International is a 501(c)3 tax-exempt organization.
Cookie | Duration | Description |
---|---|---|
CONSENT | 16 years 6 months 14 days 2 hours 6 minutes | No description |
cookielawinfo-checkbox-functional | 1 year | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-others | 1 year | No description |